TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.

Martin Reck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.